Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.

about

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.

Item

http://www.wikidata.org/entity/Q50262252

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@en

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@nl

type

Item

label

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@en

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@nl

prefLabel

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@en

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@nl

P1476

Trend of estimated glomerular ...... HIV/HCV co-infected patients.

@en

P2093

Andrea Giacometti

http://www.w3.org/2001/XMLSchema#string

Angiola Spinetti

http://www.w3.org/2001/XMLSchema#string

Annalisa Saracino

http://www.w3.org/2001/XMLSchema#string

Annamaria Cattelan

http://www.w3.org/2001/XMLSchema#string

Antonella D'Arminio Monforte

http://www.w3.org/2001/XMLSchema#string

Antonio Chirianni

http://www.w3.org/2001/XMLSchema#string

Bruno Cacopardo

http://www.w3.org/2001/XMLSchema#string

Caterina Pasquazzi

http://www.w3.org/2001/XMLSchema#string

Claudio Mastroianni

http://www.w3.org/2001/XMLSchema#string

Daniela Segala

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

HIV and kidney diseases: 35 years of history and consequences

Anti-hepatitis C virus drugs and kidney

HIV associated kidney diseases: Clarifying concordance between renal failure in HIV infection and histopathologic manifestations at kidney biopsy.

Hepatitis C virus associated glomerulopathies.

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with pre

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

P304

e0192627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0192627

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29462201

http://www.w3.org/2001/XMLSchema#string

P932

5819795

http://www.w3.org/2001/XMLSchema#string